Hepatic Mitochondrial Metabolism in Fatty Liver Diseases in Humans

Description of the granted funding

Fatty liver diseases (FLDs) related to obesity and alcohol use affect up to a quarter of the population, but their pathogenesis is poorly understood, and available medications are scarce. In this series of studies, we will investigate the energy motors of the liver – mitochondria – and their dysfunction as a key mechanism in the pathogenesis of FLDs. We will study mitochondrial dysfunction in FLD patients before and after distinct treatments by using the newest, safe tracer-based techniques. We will also use these precise techniques to study the effects of acquired risk factors of FLDs on hepatic mitochondrial function. In addition, we will investigate the association between hepatic mitochondrial dysfunction and FLDs in large population-based cohorts. These studies are expected to provide important new information on the pathogenesis of FLDs with respect to acquired and inherited risk factors. The results may also help in the development of new medical therapies for FLDs.
Show more

Starting year

2022

End year

2026

Granted funding

Panu Luukkonen Orcid -palvelun logo
239 129 €

Funder

Research Council of Finland

Funding instrument

Clinical researcher

Decision maker

Scientific Council for Biosciences, Health and the Environment
30.05.2022

Other information

Funding decision number

350545

Research fields

Kliiniset lääketieteet

Identified topics

diabetes, medicine, metabolic diseases